Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2441 – 2460 of 3242

Adherence to the Continuum of Care

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/adherence-continuum-care

Antiretroviral Use In The Context of Coinfections

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/antiretroviral-use-context-coinfections

Tuberculosis/HIV Coinfection

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/coinfections-tuberculosis-hiv

Appendix C. Key to Acronyms

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/appendix-c-key-acronyms

Appendix C: Drug Name Abbreviations

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-name-abbreviations

Antepartum HIV Care

https://clinicalinfo.hiv.gov/guidelines/perinatal/prepregnancy-counseling-childbearing-age

Indinavir (Crixivan, IDV)

https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-indinavir-crixivan

Appendix A: Pediatric Antiretroviral Drug Information

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/appendix-pediatric-antiretroviral-drug-information

Pharmacokinetic Enhancers

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/pharmacokinetic-enhancers

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/ritonavir

Appendix B: Acronyms

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/appendix-b-acronyms

Laboratory Testing

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/laboratory-testing

Management of People With HIV and Antiretroviral Therapy Experience

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/management-people-hiv-and

Optimizing Antiretroviral Therapy in the Setting of Viral Suppression

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/optimizing-antiretroviral-therapy

Integrase Inhibitors

https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/integrase-inhibitors

Cost Considerations and Antiretroviral Therapy

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/antiretroviral-therapy-cost-considerations

Management of Medication Toxicity or Intolerance

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/management-medication-toxicity-or-intolerance

Hematologic Effects

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/hematologic-effects

Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/non-nucleoside-analogue-reverse-transcriptase

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/nevirapine